These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 34742485)

  • 1. Vascular Tumors of Bone: Updates and Diagnostic Pitfall.
    Hung YP
    Surg Pathol Clin; 2021 Dec; 14(4):645-663. PubMed ID: 34742485
    [TBL] [Abstract][Full Text] [Related]  

  • 2. FOSB is a Useful Diagnostic Marker for Pseudomyogenic Hemangioendothelioma.
    Hung YP; Fletcher CD; Hornick JL
    Am J Surg Pathol; 2017 May; 41(5):596-606. PubMed ID: 28009608
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostically Challenging Epithelioid Vascular Tumors.
    Ko JS; Billings SD
    Surg Pathol Clin; 2015 Sep; 8(3):331-51. PubMed ID: 26297060
    [TBL] [Abstract][Full Text] [Related]  

  • 4. What is new in endothelial neoplasia?
    Papke DJ; Hornick JL
    Virchows Arch; 2020 Jan; 476(1):17-28. PubMed ID: 31463731
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Loss of expression of YAP1 C-terminus as an ancillary marker for epithelioid hemangioendothelioma variant with YAP1-TFE3 fusion and other YAP1-related vascular neoplasms.
    Anderson WJ; Fletcher CDM; Hornick JL
    Mod Pathol; 2021 Nov; 34(11):2036-2042. PubMed ID: 34148063
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Primary Vascular Tumors of Bone: A Monoinstitutional Morphologic and Molecular Analysis of 427 Cases With Emphasis on Epithelioid Variants.
    Righi A; Sbaraglia M; Gambarotti M; Gibertoni D; Rovira MP; Benini S; Errani C; Brenca M; Maestro R; Dei Tos AP
    Am J Surg Pathol; 2020 Sep; 44(9):1192-1203. PubMed ID: 32271190
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NR1D1::MAML1 epithelioid and spindle cell sarcoma mimicking pseudomyogenic hemangioendothelioma in core biopsy: A case report and review of the literature.
    Warmke LM; Collier CD; Davis JL
    Genes Chromosomes Cancer; 2023 Nov; 62(11):655-662. PubMed ID: 37326138
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Malignant vascular tumors--an update.
    Antonescu C
    Mod Pathol; 2014 Jan; 27 Suppl 1():S30-8. PubMed ID: 24384851
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epithelioid hemangioma of bone harboring FOS and FOSB gene rearrangements: A clinicopathologic and molecular study.
    Tsuda Y; Suurmeijer AJH; Sung YS; Zhang L; Healey JH; Antonescu CR
    Genes Chromosomes Cancer; 2021 Jan; 60(1):17-25. PubMed ID: 33034932
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic utility of FOSB immunohistochemistry in pseudomyogenic hemangioendothelioma and its histological mimics.
    Sugita S; Hirano H; Kikuchi N; Kubo T; Asanuma H; Aoyama T; Emori M; Hasegawa T
    Diagn Pathol; 2016 Aug; 11(1):75. PubMed ID: 27515856
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vascular tumors of intermediate malignancy: An update.
    Folpe AL
    Hum Pathol; 2024 May; 147():114-128. PubMed ID: 38360216
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vascular Tumors of Bone: The Evolvement of a Classification Based on Molecular Developments.
    van IJzendoorn DGP; Bovée JVMG
    Surg Pathol Clin; 2017 Sep; 10(3):621-635. PubMed ID: 28797505
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CAMTA-1 Expression in 24 Cases of Hepatic Epithelioid Hemangioendothelioma in a Single Institute: Diagnostic Utility for Differential Diagnosis from Hepatic Angiosarcoma.
    Jung H; Kim HN; Jang Y; Park CK; Ha SY
    In Vivo; 2019; 33(6):2293-2297. PubMed ID: 31662570
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Primary vascular tumors of bone: a spectrum of entities?
    Verbeke SL; Bovée JV
    Int J Clin Exp Pathol; 2011 Aug; 4(6):541-51. PubMed ID: 21904630
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vascular tumors of bone: A study of 17 cases other than ordinary hemangioma, with an evaluation of the relationship of hemangioendothelioma of bone to epithelioid hemangioma, epithelioid hemangioendothelioma, and high-grade angiosarcoma.
    Evans HL; Raymond AK; Ayala AG
    Hum Pathol; 2003 Jul; 34(7):680-9. PubMed ID: 12874764
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic stratification of clinical and molecular epithelioid hemangioendothelioma subsets.
    Rosenbaum E; Jadeja B; Xu B; Zhang L; Agaram NP; Travis W; Singer S; Tap WD; Antonescu CR
    Mod Pathol; 2020 Apr; 33(4):591-602. PubMed ID: 31537895
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epithelioid Vascular Tumors: A Review.
    Shon W; Billings SD
    Adv Anat Pathol; 2019 May; 26(3):186-197. PubMed ID: 30762622
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ZFP36-FOSB fusion defines a subset of epithelioid hemangioma with atypical features.
    Antonescu CR; Chen HW; Zhang L; Sung YS; Panicek D; Agaram NP; Dickson BC; Krausz T; Fletcher CD
    Genes Chromosomes Cancer; 2014 Nov; 53(11):951-9. PubMed ID: 25043949
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nuclear Expression of CAMTA1 Distinguishes Epithelioid Hemangioendothelioma From Histologic Mimics.
    Doyle LA; Fletcher CD; Hornick JL
    Am J Surg Pathol; 2016 Jan; 40(1):94-102. PubMed ID: 26414223
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CAMTA1 immunostaining is not useful in differentiating epithelioid hemangioendothelioma from its potential mimickers.
    Yusıflı Z; Kösemehmetoğlu K
    Turk Patoloji Derg; 2014; 30(3):159-65. PubMed ID: 25110239
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.